648 related articles for article (PubMed ID: 33243535)
21. Disparities in Emergency Department Naloxone and Buprenorphine Initiation.
Papp J; Emerman C
West J Emerg Med; 2023 Jun; 24(4):710-716. PubMed ID: 37527392
[TBL] [Abstract][Full Text] [Related]
22. Development of a take-home naloxone program at an urban academic emergency department.
Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
[TBL] [Abstract][Full Text] [Related]
23. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
[TBL] [Abstract][Full Text] [Related]
24. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
Hu T; Snider-Adler M; Nijmeh L; Pyle A
CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
[TBL] [Abstract][Full Text] [Related]
25. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
[TBL] [Abstract][Full Text] [Related]
26. Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.
Samuels EA; Baird J; Yang ES; Mello MJ
Acad Emerg Med; 2019 Feb; 26(2):160-173. PubMed ID: 30074673
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
[TBL] [Abstract][Full Text] [Related]
28. Emergency department physicians' and pharmacists' perspectives on take-home naloxone.
Holland TJ; Penm J; Dinh M; Aran S; Chaar B
Drug Alcohol Rev; 2019 Feb; 38(2):169-176. PubMed ID: 30697852
[TBL] [Abstract][Full Text] [Related]
29. Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation.
Sun T; Aroke H; Kogut S; Katenka N; Bratberg J; Buchanan A
Am J Drug Alcohol Abuse; 2022 Mar; 48(2):217-225. PubMed ID: 34780312
[No Abstract] [Full Text] [Related]
30. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
[TBL] [Abstract][Full Text] [Related]
31. Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management.
Sidlak A; Dibble B; Dhaliwal M; Bottone P; Marino R; Henry L; Howell J
Drug Alcohol Depend; 2024 May; 258():111136. PubMed ID: 38518662
[TBL] [Abstract][Full Text] [Related]
32. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
[TBL] [Abstract][Full Text] [Related]
33. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
[TBL] [Abstract][Full Text] [Related]
34. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
[TBL] [Abstract][Full Text] [Related]
35. Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use Pilot.
Hern HG; Lara V; Goldstein D; Kalmin M; Kidane S; Shoptaw S; Tzvieli O; Herring AA
Prehosp Emerg Care; 2023; 27(3):334-342. PubMed ID: 35420925
[TBL] [Abstract][Full Text] [Related]
36. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
[TBL] [Abstract][Full Text] [Related]
37. Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic.
Chieh K; Patel I; Walter L; Li L
Harm Reduct J; 2022 Jul; 19(1):84. PubMed ID: 35883136
[TBL] [Abstract][Full Text] [Related]
38. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
[TBL] [Abstract][Full Text] [Related]
39. Predictive Factors Associated with Naloxone Prescription among Pregnant People Admitted for the Management of Opioid Use Disorder.
Gonzalez AM; Arlandson ME; Patel A; Premkumar A
Am J Perinatol; 2024 Apr; 41(5):539-542. PubMed ID: 36351448
[TBL] [Abstract][Full Text] [Related]
40. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]